IL6 and viral infectious disease: An alternative discipline is the harnessing of host biomarkers such as C-reactive protein or Interleukin 6 (IL-6) to discriminate between groups of patients (e.g. CNS infections vs. other diseases and bacterial vs. viral infections) or to identify specific aetiologies.